| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.29 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |